22.25

0.76% 0.1579

Elanco Animal Health Inc (ELAN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$22.09

Offen:

$22.14

24-Stunden-Volumen:

2.22M

Relative Volume:

0.42

Marktkapitalisierung:

$11.04B

Einnahmen:

$4.45B

Nettoeinkommen (Verlust:

$205.00M

KGV:

55.62

EPS:

0.4

Netto-Cashflow:

$372.00M

1W Leistung:

+4.55%

1M Leistung:

+3.72%

6M Leistung:

+66.98%

1J Leistung:

+88.31%

1-Tages-Spanne:

$21.94

$22.35

1-Wochen-Bereich:

$21.43

$22.69

52-Wochen-Spanne:

$8.02

$23.70

Elanco Animal Health Inc Stock (ELAN) Company Profile

Firmenname

Elanco Animal Health Inc

Sektor

Healthcare (1136)

Branche

Drug Manufacturers - Specialty & Generic (84)

Telefon

877-352-6261

Adresse

450 ELANCO CIRCLE, INDIANAPOLIS

Mitarbeiter

9,450

Twitter

@Elanco

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

ELAN's Discussions on Twitter

Vergleichen Sie ELAN mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ELAN Elanco Animal Health Inc	22.21	10.98B	4.45B	205.00M	372.00M	0.40
ZTS Zoetis Inc	123.67	54.10B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	14.97	46.85B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.955	43.82B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	30.42	34.79B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	515.66	21.83B	3.08B	1.24B	1.07B	25.61

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Overweight
2025-11-21	Eingeleitet	KeyBanc Capital Markets	Overweight
2025-11-19	Hochstufung	Argus	Hold → Buy
2025-10-07	Hochstufung	JP Morgan	Neutral → Overweight
2025-07-17	Hochstufung	Leerink Partners	Market Perform → Outperform
2025-06-26	Hochstufung	William Blair	Mkt Perform → Outperform
2024-12-09	Eingeleitet	UBS	Buy
2024-12-02	Eingeleitet	Leerink Partners	Market Perform
2024-09-19	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-01-05	Hochstufung	Stifel	Hold → Buy
2023-12-19	Eingeleitet	Jefferies	Buy
2023-12-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-12-07	Eingeleitet	Exane BNP Paribas	Outperform
2023-04-20	Hochstufung	Barclays	Equal Weight → Overweight
2022-08-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2022-08-16	Herabstufung	JP Morgan	Overweight → Neutral
2022-07-21	Herabstufung	Goldman	Buy → Sell
2022-07-12	Eingeleitet	Piper Sandler	Neutral
2021-11-18	Eingeleitet	Morgan Stanley	Overweight
2021-10-28	Herabstufung	Stifel	Buy → Hold
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2021-06-15	Hochstufung	Cleveland Research	Underperform → Neutral
2021-05-11	Hochstufung	Barclays	Underweight → Equal Weight
2021-05-11	Hochstufung	Gabelli & Co	Hold → Buy
2021-04-15	Eingeleitet	Stifel	Buy
2021-03-22	Herabstufung	Gabelli & Co	Buy → Hold
2021-02-26	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-09	Herabstufung	Argus	Buy → Hold
2020-11-09	Herabstufung	Barclays	Overweight → Underweight
2020-08-20	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-08-13	Fortgesetzt	Credit Suisse	Neutral
2020-08-04	Fortgesetzt	Goldman	Buy
2020-07-27	Herabstufung	Cleveland Research	Neutral → Underperform
2020-04-02	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2020-01-10	Eingeleitet	Raymond James	Mkt Perform
2019-12-19	Hochstufung	BofA/Merrill	Neutral → Buy
2019-11-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2019-09-23	Eingeleitet	Barclays	Overweight
2019-08-26	Herabstufung	BofA/Merrill	Buy → Neutral
2019-08-15	Hochstufung	UBS	Sell → Neutral
2019-05-23	Eingeleitet	Guggenheim	Neutral
2019-03-18	Hochstufung	BofA/Merrill	Neutral → Buy
2019-03-13	Fortgesetzt	Morgan Stanley	Equal-Weight
2019-02-12	Eingeleitet	William Blair	Mkt Perform
2019-01-23	Eingeleitet	UBS	Sell
2019-01-15	Eingeleitet	Argus	Buy
2018-10-15	Eingeleitet	Morgan Stanley	Equal-Weight

Alle ansehen

Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten

03:47 AM

Will Elanco Animal Health Incorporated stock benefit from automationEarnings Summary Report & AI Enhanced Trading Signals - Bölüm Sonu Canavarı

03:47 AM

02:32 AM

Is Elanco Animal Health Incorporated (5EA) stock positioned for digital growth eraTrade Risk Assessment & Target Return Focused Picks - DonanımHaber

02:32 AM

01:30 AM

Elanco CEO Bites Off More Shares of Fast-Rising Stock - Barron's

01:30 AM

01:29 AM

Companion Animal Vaccine Market is Going to Boom: New Report - openPR.com

01:29 AM

Dec 18, 2025

Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Steve Cohen, Citadel Investment Group, Elliott Management, Altai Capital, Elanco Animal Health Inc (ELAN), NVIDIA Corp (NVDA), and More - Insider Monkey

Dec 18, 2025

Elanco focused on production animals - norfolkneradio.com

Dec 18, 2025

Elanco Animal Health (NYSE:ELAN) Price Target Raised to $22.00 - MarketBeat

Dec 18, 2025

FDA conditionally approves Elanco’s treatment for screwworm in dogs By Investing.com - Investing.com Australia

Dec 18, 2025

FDA conditionally approves Elanco’s treatment for screwworm in dogs - Investing.com India

Dec 18, 2025

Elanco's Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs - PR Newswire

Dec 18, 2025

Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around' - Benzinga

Dec 18, 2025

Dec 17, 2025

Elanco (ELAN): Valuation Check After Insider Buying Spree and New Restructuring Plan - Yahoo Finance

Dec 17, 2025

Dec 16, 2025

Elanco Animal Health Director Purchases 10,000 Shares - TradingView — Track All Markets

Dec 16, 2025

[Form 4] Elanco Animal Health Inc Insider Trading Activity - Stock Titan

Dec 16, 2025